Headlines about Ampliphi Biosciences Corp (NASDAQ:APHB) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Ampliphi Biosciences Corp earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.9039097273329 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Separately, HC Wainwright set a $5.00 price target on Ampliphi Biosciences Corp and gave the company a “buy” rating in a report on Monday, October 2nd.

Ampliphi Biosciences Corp (APHB) traded down $0.02 during trading hours on Tuesday, hitting $1.02. The company’s stock had a trading volume of 153,652 shares, compared to its average volume of 839,831. Ampliphi Biosciences Corp has a 1 year low of $0.67 and a 1 year high of $11.00.

Ampliphi Biosciences Corp (NASDAQ:APHB) last released its quarterly earnings results on Monday, August 14th. The company reported ($0.78) earnings per share for the quarter, beating the consensus estimate of ($0.80) by $0.02. Ampliphi Biosciences Corp had a negative return on equity of 313.95% and a negative net margin of 23,075.00%. The firm had revenue of $0.03 million for the quarter.

COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Ampliphi Biosciences Corp (APHB) Stock Price” was reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.watchlistnews.com/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-ampliphi-biosciences-corp-aphb-stock-price/1686466.html.

About Ampliphi Biosciences Corp

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Insider Buying and Selling by Quarter for Ampliphi Biosciences Corp (NASDAQ:APHB)

Receive News & Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.